Enocitabine

Enocitabine
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	IV
ATC code	none;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name N-[1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]docosanamide;
CAS Number	55726-47-1 ;
PubChem CID	71734;
ChemSpider	64778 ;
UNII	9YVR68W306;
KEGG	D01633 ;
ChEMBL	ChEMBL2106589 ;
CompTox Dashboard (EPA)	DTXSID6046682 ;
Chemical and physical data
Formula	C31H55N3O6
Molar mass	565.796 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(N/C/1=N/C(=O)N(\C=C\1)[C@@H]2O[C@@H]([C@@H](O)[C@@H]2O)CO)CCCCCCCCCCCCCCCCCCCCC;
	InChI InChI=1S/C31H55N3O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-27(36)32-26-22-23-34(31(39)33-26)30-29(38)28(37)25(24-35)40-30/h22-23,25,28-30,35,37-38H,2-21,24H2,1H3,(H,32,33,36,39)/t25-,28-,29+,30-/m1/s1 ; Key:SAMRUMKYXPVKPA-VFKOLLTISA-N ;

Enocitabine (INN, marketed under the brand name Sunrabin) is a nucleoside analog used as chemotherapy.

Sunrabin contains the emulsifier HCO-60, which can cause allergic reactions.^[1]

References

^ Tatetsu H, Asou N, Nakamura M, et al. (July 2003). "[Allergic reaction against an emulsifier, HCO-60, contained in multamin and enocitabine]". Rinsho Ketsueki (in Japanese). 44 (7): 471–3. PMID 12931567.

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.